Guanfacine 2 MG Oral Tablet — RxCUI 197746
RxNorm drug concept · Semantic clinical drug
RxCUI 197746
Semantic clinical drug · SCD
● Current RxNorm concept 34 FDA products
46 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197746
Official nameGuanfacine 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asguanfacine 2 MG (as guanfacine HCl 2.3 MG) Oral Tablet; guanFACINE HCl 2 MG Oral Tablet
FDA products mapped34
Package NDCs mapped46
Reported Medicaid activity (SDUD)1,252,396 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Guanfacine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's used for both, depending on which form you have. The regular (immediate-release) tablet is prescribed for high blood pressure. The extended-release version — brand name Intuni...
- What is guanfacine actually used for — is it for ADHD or blood pressure?
- No, Intuniv is not a stimulant at all. It works on a different part of the brain than medications like Adderall or Ritalin. That's actually one reason it's sometimes used alongside...
- My child takes Intuniv for ADHD — is it a stimulant?
🕸️ Concept Web — How Guanfacine 2 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Guanfacine 2 MG Oral Tablet
RxCUI 197746 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Guanfacine
40114IN
-
Guanfacine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Guanfacine Oral Tablet
372368SCDF -
Guanfacine Oral Product
1159714SCDG -
Guanfacine Pill
1159715SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Guanfacine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Guanfacine 2 MG
329796SCDC
-
Guanfacine 2 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Guanfacine 2 MG
SCDC · 329796 -
Guanfacine Oral Tablet
SCDF · 372368 -
Guanfacine Oral Product
SCDG · 1159714 -
Guanfacine Pill
SCDG · 1159715
📦 FDA Products & Package NDCs
34 products · 46 package NDCs
46 package NDCs map to RxCUI 197746 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00591-0444-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-0444-01) | Guanfacine | Actavis Pharma, Inc. | 1995-10-17 |
| 00591-0453-01 | 100 TABLET in 1 BOTTLE (0591-0453-01) | Guanfacine | Actavis Pharma, Inc. | 1995-10-17 |
| 24658-0730-01 | 100 TABLET in 1 BOTTLE (24658-730-01) | Guanfacine | PuraCap Laboratories LLC dba Blu Pharmaceuticals | 2016-11-14 |
| 24979-0198-01 | 100 TABLET in 1 BOTTLE (24979-198-01) | Guanfacine Hydrochloride | TWi Pharmaceuticals, Inc. | 2022-09-01 |
| 24979-0199-01 | 100 TABLET in 1 BOTTLE (24979-199-01) | Guanfacine Hydrochloride | TWi Pharmaceuticals, Inc. | 2022-09-01 |
| 27241-0242-01 | 100 TABLET in 1 BOTTLE (27241-242-01) | Guanfacine | Ajanta Pharma USA Inc. | 2023-04-27 |
| 27241-0243-01 | 100 TABLET in 1 BOTTLE (27241-243-01) | Guanfacine | Ajanta Pharma USA Inc. | 2023-04-27 |
| 29300-0458-01 | 100 TABLET in 1 BOTTLE (29300-458-01) | Guanfacine Hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2021-04-05 |
| 29300-0459-01 | 100 TABLET in 1 BOTTLE (29300-459-01) | Guanfacine Hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2021-04-05 |
| 42806-0048-01 | 100 TABLET in 1 BOTTLE (42806-048-01) | Guanfacine | Epic Pharma, LLC | 2013-12-02 |
| 42806-0296-01 | 100 TABLET in 1 BOTTLE (42806-296-01) | Guanfacine | Epic Pharma, LLC | 2019-05-30 |
| 50268-0374-15 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-374-15) / 1 TABL... | Guanfacine Hydrochloride | AvPAK | 2017-06-07 |
| 53746-0711-01 | 100 TABLET in 1 BOTTLE (53746-711-01) | Guanfacine Hydrochloride | Amneal Pharmaceuticals of New York LLC | 2022-04-15 |
| 53746-0713-01 | 100 TABLET in 1 BOTTLE (53746-713-01) | Guanfacine Hydrochloride | Amneal Pharmaceuticals of New York LLC | 2022-04-15 |
| 59651-0840-01 | 100 TABLET in 1 BOTTLE (59651-840-01) | GUANFACINE | Aurobindo Pharma Limited | 2023-08-07 |
| 59651-0841-01 | 100 TABLET in 1 BOTTLE (59651-841-01) | GUANFACINE | Aurobindo Pharma Limited | 2023-08-07 |
| 62135-0727-90 | 90 TABLET in 1 BOTTLE (62135-727-90) | GUANFACINE HYDROCHLORIDE | Chartwell RX, LLC | 2023-07-12 |
| 62135-0728-90 | 90 TABLET in 1 BOTTLE (62135-728-90) | GUANFACINE HYDROCHLORIDE | Chartwell RX, LLC | 2023-07-12 |
| 65162-0711-03 | 30 TABLET in 1 BOTTLE (65162-711-03) | Guanfacine Hydrochloride | Amneal Pharmaceuticals LLC | 1998-11-25 |
| 65162-0711-10 | 100 TABLET in 1 BOTTLE (65162-711-10) | Guanfacine Hydrochloride | Amneal Pharmaceuticals LLC | 1998-11-25 |
| 65162-0713-03 | 30 TABLET in 1 BOTTLE (65162-713-03) | Guanfacine Hydrochloride | Amneal Pharmaceuticals LLC | 1998-11-25 |
| 65162-0713-10 | 100 TABLET in 1 BOTTLE (65162-713-10) | Guanfacine Hydrochloride | Amneal Pharmaceuticals LLC | 1998-11-25 |
| 65162-0713-50 | 500 TABLET in 1 BOTTLE (65162-713-50) | Guanfacine Hydrochloride | Amneal Pharmaceuticals LLC | 1998-11-25 |
| 67046-1655-03 | 30 TABLET in 1 BLISTER PACK (67046-1655-3) | Guanfacine | Coupler LLC | 2026-01-28 |
| 70518-3516-00 | 30 TABLET in 1 BLISTER PACK (70518-3516-0) | Guanfacine Hydrochloride | REMEDYREPACK INC. | 2022-09-13 |
| 70518-4488-00 | 30 TABLET in 1 BLISTER PACK (70518-4488-0) | Guanfacine | REMEDYREPACK INC. | 2025-09-30 |
| 70518-4564-00 | 30 TABLET in 1 BLISTER PACK (70518-4564-0) | Guanfacine | REMEDYREPACK INC. | 2026-02-03 |
| 70700-0301-01 | 100 TABLET in 1 BOTTLE (70700-301-01) | Guanfacine Hydrochloride | XIROMED, LLC | 2024-02-24 |
| 70700-0301-30 | 30 TABLET in 1 BOTTLE (70700-301-30) | Guanfacine Hydrochloride | XIROMED, LLC | 2024-02-24 |
| 70700-0302-01 | 100 TABLET in 1 BOTTLE (70700-302-01) | Guanfacine Hydrochloride | XIROMED, LLC | 2024-02-24 |
| 70700-0302-05 | 500 TABLET in 1 BOTTLE (70700-302-05) | Guanfacine Hydrochloride | XIROMED, LLC | 2024-02-24 |
| 70700-0302-30 | 30 TABLET in 1 BOTTLE (70700-302-30) | Guanfacine Hydrochloride | XIROMED, LLC | 2024-02-24 |
| 72319-0018-04 | 100 TABLET in 1 BOTTLE (72319-018-04) | Guanfacine | i3 Pharmaceuticals, LLC | 2022-10-31 |
| 72319-0019-04 | 100 TABLET in 1 BOTTLE (72319-019-04) | Guanfacine | i3 Pharmaceuticals, LLC | 2022-10-31 |
| 72603-0268-01 | 100 TABLET in 1 BOTTLE (72603-268-01) | Guanfacine Hydrochloride | NORTHSTAR RX LLC | 2024-07-15 |
| 72603-0269-01 | 100 TABLET in 1 BOTTLE (72603-269-01) | Guanfacine Hydrochloride | NORTHSTAR RX LLC | 2024-07-15 |
| 72888-0123-00 | 1000 TABLET in 1 BOTTLE (72888-123-00) | Guanfacine | Advagen Pharma Ltd | 2021-10-01 |
| 72888-0123-01 | 100 TABLET in 1 BOTTLE (72888-123-01) | Guanfacine | Advagen Pharma Ltd | 2021-10-01 |
| 72888-0123-05 | 500 TABLET in 1 BOTTLE (72888-123-05) | Guanfacine | Advagen Pharma Ltd | 2021-10-01 |
| 72888-0123-30 | 30 TABLET in 1 BOTTLE (72888-123-30) | Guanfacine | Advagen Pharma Ltd | 2021-10-01 |
| 72888-0124-00 | 1000 TABLET in 1 BOTTLE (72888-124-00) | Guanfacine | Advagen Pharma Ltd | 2021-10-01 |
| 72888-0124-01 | 100 TABLET in 1 BOTTLE (72888-124-01) | Guanfacine | Advagen Pharma Ltd | 2021-10-01 |
| 72888-0124-05 | 500 TABLET in 1 BOTTLE (72888-124-05) | Guanfacine | Advagen Pharma Ltd | 2021-10-01 |
| 72888-0124-30 | 30 TABLET in 1 BOTTLE (72888-124-30) | Guanfacine | Advagen Pharma Ltd | 2021-10-01 |
| 73141-0018-04 | 100 TABLET in 1 BOTTLE (73141-018-04) | Guanfacine | A2A Integrated Pharmaceuticals | 2025-04-08 |
| 73141-0019-04 | 100 TABLET in 1 BOTTLE (73141-019-04) | Guanfacine | A2A Integrated Pharmaceuticals | 2025-04-08 |
Observed labelers:
Advagen Pharma Ltd (8) ·
Amneal Pharmaceuticals LLC (5) ·
XIROMED, LLC (5) ·
REMEDYREPACK INC. (3) ·
A2A Integrated Pharmaceuticals (2) ·
Actavis Pharma, Inc. (2)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.